News
05-23-2012, 01:13 AM
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies...
More... (http://www.medicalnewstoday.com/releases/245667.php)
More... (http://www.medicalnewstoday.com/releases/245667.php)